Pharmaceutical

Filter

Current filters:

None

Popular Filters

6651 to 6675 of 6816 results

Pfizer Ph II study confirms efficacy of Ablynx' ozoralizumab in RA

20-05-2011

Belgian drug developer Ablynx (Euronext Brussels: ABLX) revealed top-line results from the recently…

AblynxAnti-Arthritics/RheumaticsFinancialozoralizumabPfizerPharmaceuticalResearch

Roche and Evotec terminate Ph II study with NR2B in treatment-resistant depression

20-05-2011

German biotech firm Evotec AG (Xetra: EVT) and Swiss drug major Roche (SIX: ROG) say they have decided…

BiotechnologyEvotecLicensingNeurologicalPharmaceuticalResearchRoche

Pharma distribution in Central Europe in 2011: liberalization of non-pharmacy and on-line sales

20-05-2011

Pharmaceutical distribution has been liberalized further in Central Europe in 2011, with Bulgaria making…

EuropeMarkets & MarketingPharmaceuticalRegulation

Roundup of upcoming cancer drug trials to be presented at ASCO

20-05-2011

A number of leading pharmaceutical companies – include Pfizer, Bayer, Roche and AstraZeneca - have…

AstraZenecaaxitinibBayerMetMAbNexavarolaparibOncologyPfizerPharmaceuticalResearchRoche

FDA advisory panel backs continued use of Abbott’s Trilipix with statins

20-05-2011

The US Food and Drug Administration’s Endocrinologic and Metabolic Drugs Advisory Committee to review…

Abbott LaboratoriesCardio-vascularNorth AmericaPharmaceuticalRegulationTrilipix

Record $3 billion disbursed in 2010 by Global Fund to Fight AIDS

20-05-2011

The Global Fund to Fight AIDS, Tuberculosis and Malaria disbursed a record $3 billion in 2010. This helped…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalTropical diseases

10% of US cancer patients abandoned oral drug therapy, often on cost grounds

20-05-2011

In the USA, 10% of cancer patients failed to fill their initial prescriptions for oral anti-cancer drugs,…

HealthcareNorth AmericaOncologyPharmaceuticalPricing

Nycomed agrees to 9.6 billion euros takeover by Takeda

19-05-2011

Despite just yesterday again saying that it "has not agreed to any such an agreement," this morning Takeda…

Mergers & AcquisitionsNycomedPharmaceuticalTakeda Pharmaceuticals

Global pharma market will see just 3%-6% growth over next five years, reaching $1,100 billion in 2015

19-05-2011

Global spending for medicines will reach nearly $1,100 billion by 2015, reflecting a slowing compound…

GenericsGlobalMarkets & MarketingPatentsPharmaceutical

Astellas’ mirabegron improves key OAB symptoms in Ph III study

19-05-2011

The US subsidiary of Japanese drug major Astellas (TSE: 4503) says that the results of a pivotal Phase…

Astellas PharmaGastro-intestinalsmirabegronPharmaceuticalResearch

Public Citizen says US FDA should immediately pull Eisai and Pfizer’s high-dose Aricept from market

19-05-2011

US consumer watchdog Public Citizen has called for higher doses of Aricept (donepezil), marketed by originator…

AriceptEisaiNeurologicalNorth AmericaPfizerPharmaceuticalRegulation

Amgen says Xgeva first drug to prevent spread of bone cancer in prostate cancer patients

19-05-2011

Amgen (Nasdaq: AMGN), the world’s largest biotech company, has announced primary results of a pivotal…

AmgenBiotechnologyOncologyPharmaceuticalResearchXgeva

Eisai gets Swiss approval for Halaven

19-05-2011

Japanese drug major Eisai (TYO: 4532), says that its Halaven(eribulin) has been approved for use in…

EisaiEuropeHalavenOncologyPharmaceuticalRegulation

Satisfaction with gastric cancer treatment options remains low, GfK study notes

19-05-2011

In just over a month following the US Food and Drug Administration’s approval last fall of Swiss…

HerceptinMarkets & MarketingOncologyPharmaceuticalRoche

New treatment avenue identified for breast cancer

19-05-2011

Researchers at the CHUM Research Centre (CRCHUM) and the Peter MacCallum Cancer Centre in Australia have…

HerceptinOncologyPharmaceuticalResearchRoche

Indian-Danish contract research merger

19-05-2011

Following its acquisition of a majority stake in the Danish firm, India-based Ecron Acunova, a full-service…

aCROnordicEcron AcunovaMergers & AcquisitionsPharmaceutical

Shire to buy regenerative medicines firm Advanced BioHealing for $750 million

18-05-2011

Ireland-headquartered biopharmaceutical firm Shire (LSE: SHP) - best known for its attention-deficit…

Advanced BioHealingDermagraftMergers & AcquisitionsPharmaceuticalShire

Pfizer files for US and Japanese approval of crizotinib for NSCLC

18-05-2011

US drug behemoth Pfizer (NYSE: PFE) says that its New Drug Application for crizotinib, an oral first-in-class…

Asia-PacificcrizotinibNorth AmericaOncologyPfizerPharmaceuticalRegulation

Turkish pharma - pushed to the limit - calling off some investments

18-05-2011

Times are hard for pharmaceutical companies in Turkey, particularly research-based ones, who are left…

EuropeFinancialMarkets & MarketingPharmaceuticalPricing

Dr Reddy’s gains Indian rights to Oceana’s Deflux

18-05-2011

Privately-held US company Oceana Therapeutics, which is focused on acquiring, developing and commercializing…

DefluxDr Reddy's LaboratoriesLicensingOceana TherapeuticsPharmaceutical

Australia’s TGA approves Biogen’s Fampyra to improve MS patients walking ability

18-05-2011

The Australian Therapeutic Goods Administration (TGA) has granted approval for USA-based Biogen Idec’s…

AmpyraAsia-PacificBiogen IdecFampyraNeurologicalPharmaceuticalRegulation

6651 to 6675 of 6816 results

Back to top